(Q37769273)

22 August 2017

1 reference

title

Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver (English)

1 reference

22 August 2017

0 references

hepatic encephalopathy

1 reference

8

1 reference

22 August 2017

6

Roger Butterworth

1 reference

22 August 2017

Radha K Dhiman

1

1 reference

22 August 2017

Vivek A Saraswat

2

1 reference

22 August 2017

Barjesh K Sharma

3

1 reference

22 August 2017

Shiv K Sarin

4

1 reference

22 August 2017

Yogesh K Chawla

5

1 reference

22 August 2017

Ajay Duseja

7

1 reference

22 August 2017

Deepak Amarapurkar

9

1 reference

22 August 2017

Praveen Sharma

10

1 reference

22 August 2017

Kaushal Madan

11

1 reference

22 August 2017

Samir Shah

12

1 reference

22 August 2017

Avnish K Seth

13

1 reference

22 August 2017

Rakesh K Gupta

14

1 reference

22 August 2017

Abraham Koshy

15

1 reference

22 August 2017

Ramesh R Rai

16

1 reference

22 August 2017

Jang B Dilawari

17

1 reference

22 August 2017

Sri Prakash Mishra

18

1 reference

22 August 2017

Subrat K Acharya

19

1 reference

22 August 2017

Indian National Association for Study of the Liver

20

1 reference

22 August 2017

1 June 2010

1 reference

Journal of Gastroenterology and Hepatology

22 August 2017

1 reference

22 August 2017

25

1 reference

22 August 2017

6

1 reference

22 August 2017

1029-1041

1 reference

Review article: the burden of hepatic encephalopathy

22 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Screening of subclinical hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Quality of life in cirrhotics with minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Minimal hepatic encephalopathy impairs fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Predictors of automobile crashes and moving violations among elderly drivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Neuropsychological characterization of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Neurophysiological investigation of hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Inhibitory control test for the diagnosis of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Diffusion-weighted MR imaging of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

High prevalence of sleep disturbance in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Memory function in early hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Astrocyte-mediated control of cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

21 January 2018

Neurobiology of ammonia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Increased aquaporin-4 expression in ammonia-treated cultured astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Effect of Ammonia on Brain Serotonin Metabolism in Relation to Function in the Portacaval Shunted Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Increased density of brain histamine H(1) receptors in rats with portacaval anastomosis and in cirrhotic patients with chronic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Role of ammonia and inflammation in minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Probiotics can treat hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

Neurophysiological assessment of early hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06318.X

10.1111/J.1440-1746.2010.06318.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference